Table 1.
Prevalence of chronic neuropathic pain following breast-conserving surgery.
| Author (year), LoE | Patients after BCS | Mean follow-up months (range) | Neuropathic pain assessment tool | Patients after BCS with neuropathic pain | % Neuropathic pain patients after BCS of total |
|---|---|---|---|---|---|
| Fuzier et al. (2022), III | 137 | 3 (0-4) | DN4 | 25 | 18.3% |
| Abdallah et al. (2021), II | 3 | 3 (0-3) | S-LANSS | 0 | 0% |
| Mustonen et al. (2019), III | 81 | 78 (48-108) | Clinical and physical evaluation (NeuPSIG) | 66 | 81.5% |
| Pereira et al. (2017), III | 236 | 13 (0-18) | Clinical and physical evaluation | 32 | 13.6% |
| Schou Bredal et al. (2014), III | 563 | 24 (24-72) | S-LANSS | 78 | 13.9% |
| Wilson et al. (2013), III | 316 | 12 (12-60) | Clinical and physical evaluation | 41 | 13.0% |
| Elkaradawy et al. (2012), II | 43 | 9 (0-12) | Clinical and physical evaluation | 31 | 72.1% |
| Carpenter et al. (1998), III | 54 | 35 (3-151) | Clinical and physical evaluation | 32 | 60.0% |
LoE, Level of evidence; BCS, Breast-conserving surgery; DN4, Douleur Neuropathique-4; S-LANSS, Self-report leeds assessment of neuropathic symptoms and sign.